A
new epidemiological study in nearly 19,000 Americans indicates that
lack of adequate vitamin D may leave people vulnerable to the common
cold and the flu.
In the largest and most nationally representative study of possible
links between vitamin D and respiratory infections, a team from
Colorado and Massachusetts found that people with the lowest blood
vitamin D levels reported having significantly more recent colds
or cases of the flu (Ginde AA et al. 2009).
The risks were even higher for those with chronic respiratory disorders,
such as asthma and emphysema.
The findings of our study support an important role for vitamin
D in prevention of common respiratory infections, such as colds
and the flu, said lead author Adit Ginde, MD, MPH of UC Denver.
Individuals with common lung diseases, such as asthma or emphysema,
may be particularly susceptible to respiratory infections from vitamin
D deficiency. (MGH 2009)
While vitamin C has been promoted for the prevention of colds, the
only scientific evidence that supports its effectiveness shows that
it may shorten their duration slightly. And there's no evidence
that vitamin C or any other nutrient prevents or treats the flu.
In contrast, evidence has accumulated in recent years suggesting
that vitamin D may play a key role in the innate immune
system, which attacks viruses and other microbes by means other
than those triggered by vaccines.
Circumstantial evidence has implicated the wintertime deficiency
of vitamin D, which the body produces in response to sunlight, in
the seasonal increase in colds and flu; and small studies have suggested
an association between low blood levels of vitamin D and a higher
risk of respiratory infections.
What the study found
The current study analyzed data from the Third National Health and
Nutrition Examination Survey (NHANES III), conducted by the National
Center for Health Statistics. Participants were interviewed in their
homes regarding their health and nutrition, and most participants
also received a physical examination that included collection of
blood and other samples for laboratory analysis.
The research team analyzed blood levels of 25-hydroxyvitamin D ?
the best measure of vitamin D status ? from almost 19,000 adult
and adolescent NHANES III participants, selected to be representative
of the overall U.S. population.
Study participants with the lowest vitamin D blood levels? less
than 10 nanograms per milliliter (ng/mL) of blood ? were about 40
percent more likely to report having a recent respiratory infection
than were those with vitamin D levels of 30 ng/mL or higher.
The association was seen in all seasons and was even stronger among
participants with a history of asthma or chronic obstructive pulmonary
disease (COPD), including emphysema.
Asthma patients with the lowest vitamin D levels were five times
more likely to have had a recent respiratory infection; while among
COPD patients, respiratory infections were twice as common among
those with vitamin D deficiency.
According to senior author Carlos Camargo, MD, DrPH, A respiratory
infection in someone with otherwise healthy lungs usually causes
a few days of relatively mild symptoms. But respiratory infections
in individuals with an underlying lung disease can cause serious
attacks of asthma or COPD that may require urgent office visits,
emergency department visits or hospitalizations. So the impact of
preventing infections in these patients could be very large.
(MGH 2009)
The authors stressed that the studys results need to be confirmed
in clinical trials before vitamin D can be recommended to prevent
colds and flu.
We are planning clinical trials to test the effectiveness
of vitamin D to boost immunity and fight respiratory infection,
with a focus on individuals with asthma and COPD, as well as children
and older adults - groups that are at higher risk for more severe
illness, Ginde says. (MGH 2009)
And he added the most important point, regardless of the fate of
vitamin D in clinical trials against colds and flu: While
its too early to make any definitive recommendations, many
Americans also need more vitamin D for its bone and general health
benefits. Clinicians and laypeople should stay tuned as this exciting
area of research continues to expand. (MGH 2009)
Why would vitamin D deter respiratory viruses?
John Cannell, M.D. is one of several researchers examining the potential
role of vitamin D in immunity.
Three years back, Dr. Cannell and leading researchers from Harvard,
Boston University, Mount Sinai Hospital Toronto, and UC San Diego
published an intriguing reexamination of influenzas causes,
titled Epidemic influenza and vitamin D.
This briefer explanation of the hypothesis that flu manifests in
the absence of adequate vitamin D ? an idea supported by the study
we report today comes from a question-answer column in the May 2009
issue of his Vitamin D Newsletter:
Dr. Cannell: How does Vitamin D work in the immune system?
Philip,
Texas
Two systems exist in your body to fight infections, the innate
or immediate system and the acquired or adaptive immune system that
makes antibodies.
Recent evidence indicates seasonal impairments of the antimicrobial
peptide (AMPs) systems are crucial to impaired innate immunity,
impairments caused by seasonal fluctuations in 25-hydroxyvitamin
D [25(OH)D] levels. The evidence that vitamin D has profound effects
on innate immunity is rapidly growing.
Unlike adaptive immunity, innate immunity is that branch of
host defense that is hard-wired to respond rapidly to
microorganisms using genetically encoded effectors that are ready
for activation by an antigen before the body has ever encountered
that antigen.
Of the effectors, the best studied are the antimicrobial peptides
(AMPs). Both epithelial tissues and phagocytic blood cells produce
AMPs; they exhibit rapid and broad-spectrum antimicrobial activity
against bacteria, fungi, and viruses. In general, they act by rapidly
and irreversibly damaging the lipoprotein membranes of microbial
targets, including enveloped viruses, like influenza.
Antimicrobial peptides protect mucosal epithelial surfaces
by creating a hostile antimicrobial barricade. The epithelia secrete
them constitutively into the thin layer of fluid that lies above
the apical surface of the epithelium but below the viscous mucous
layer.
To effectively access the epithelium, a microbe must first
infiltrate the mucous barrier and then survive assault by the AMPs
present in this fluid. Should microbes breach this constitutive
cordon, their binding to the epithelium rapidly mobilizes the expression
of high concentrations of specific inducible AMPs, which provide
a backup antimicrobial shield.
The crucial role of vitamin D in the innate immune system
was discovered only very recently. Both epithelial cells and macrophages
[microbe-eating white blood cells] increase expression of the antimicrobial
[compound] cathelicidin upon exposure to microbes, an expression
that is dependent upon the presence of vitamin D. Pathogenic microbes
stimulate the production of an enzyme that converts 25(OH)D to 1,25(OH)2D,
a seco-steroid hormone. This in turn rapidly activates a suite of
genes involved in pulmonary defense.
In the macrophage [microbe-eating white blood cell], the presence
of vitamin D also appears to suppress the pro-inflammatory cytokines.
Thus, vitamin D appears to both enhance the local capacity of the
epithelium to produce endogenous antibiotics and at the same time
dampen certain destructive arms of the immune response, especially
those responsible for the signs and symptoms of acute inflammation,
such as the cytokine storms operative when influenza kills quickly.
Because humans obtain most vitamin D from sun exposure and
not from diet, a varying percentage of the population is vitamin
D deficient, at any time, during any season, at any latitude, although
the percentage is higher in the winter, in the aged, in the obese,
in the sun-deprived, in the dark-skinned, and in more poleward [northern]
populations.
However, seasonal variation of vitamin D levels even occur
around the equator and widespread vitamin D deficiency can occur
at equatorial latitudes, probably due to sun avoidance, rainy seasons,
and air pollution.
For example, a study of Hong Kong infants showed about half
had 25(OH)D levels less than 20 ng/mL in the winter. Even in the
summer, few of the infants had levels higher than 30 ng/mL, which
many experts now think is well below the lower limit of the optimal
range.
As 25(OH)D levels affect innate immunity, then a varying percentage
of most populations even equatorial ones will have impaired innate
immunity at any given time, together with distinct seasonal variations
in that percentage. The effects such impairments have on influenza
transmission are unknown.
Editor's
note:
We
consider organic whole foods from both plant and animal kingdoms
to be a major key to superior health. We also think it's terribly
important to eat fish at least twice a week to get the essential
fatty acids. Here at our house, we only eat wild Alaskan salmon
and other wild seafoods from our friends at Vital Choice.
Click
here to visit Vital Choice Seafood.
Sources:
*Ginde
AA, Liu MC, Camargo CA Jr. Demographic differences and trends of
vitamin D insufficiency in the US population, 1988-2004. Arch Intern
Med. 2009 Mar 23;169(6):626-32.
*Massachusetts General Hospital (MGH). February 23, 2009. Vitamin
D deficiency may increase risk of colds, flu. Accessed online at
http://www.massgeneral.org/about/pressrelease.aspx?id=1103
*Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S,
Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol
Infect. 2006 Dec;134(6):1129-40. Epub 2006 Sep 7. Review.
Click
Here to
share this page with your friends, website visitors, ezine readers, social followers
and other online contacts.
Disclaimer:
Throughout this website, statements are made pertaining to the properties and/or
functions of food and/or nutritional products. These statements have not been
evaluated by the Food and Drug Administration and these materials and products
are not intended to diagnose, treat, cure or prevent any disease.